Induction of Vascular Networks in Adult Organs: Implications to Proangiogenic Therapy
- 1 May 2003
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 995 (1) , 208-216
- https://doi.org/10.1111/j.1749-6632.2003.tb03224.x
Abstract
Abstract: Most therapeutic proangiogenic approaches rely on the premise that a single factor (e.g., VEGF) can induce new vascular loops properly connected to the existing vasculature of an ill‐perfused organ (e.g., the ischemic myocardium). To gain insights into VEGF‐driven neovascularization in the adult, in general, and to uncover inherent obstacles in VEGF‐based therapeutic angiogenesis, we have used a transgenic system for conditional “on” and “off” switching of VEGF expression in selected adult organs and analytical methods for three‐dimensional visualization of the induced vascular network. VEGF induces massive accumulation of endothelial progenitor cells and their subsequent coalescence into new vascular loops. Continual ramification of the vasculature and fusion of adjacent vessels culminate in formation of hemangioma‐like vessels. In the absence of guiding cues, abnormal branching patterns and random connections with the existing network are formed. Following cessation of the VEGF stimulus, the acquired network undergoes extensive hemodynamic remodeling acting to “normalize” its architecture. Premature withdrawal of VEGF leads to regression of most acquired vessels, thus challenging the utility of therapeutic approaches relying on short stimulus duration. Overproduction of VEGF leads also to highly disruptive edema, thereby emphasizing the need to uncouple VEGF‐induced permeability from its angiogenic activity. This genetic switch system thus highlights remaining problems critical for the implementation of proangiogenic therapy.Keywords
This publication has 15 references indexed in Scilit:
- Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?Nature Reviews Cancer, 2002
- Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawalJournal of Clinical Investigation, 1999
- Ischemia-Driven AngiogenesisTrends in Cardiovascular Medicine, 1997
- Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient MiceScience, 1997
- Control of Memory Formation Through Regulated Expression of a CaMKII TransgeneScience, 1996
- Conditional Transgene Expression in the HeartCirculation Research, 1996
- Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice.Proceedings of the National Academy of Sciences, 1996
- Heterozygous embryonic lethality induced by targeted inactivation of the VEGF geneNature, 1996
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleNature, 1996
- Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurityNature Medicine, 1995